Clinical trial

Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication

NCT07272902

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Catheter Ablation for Atrial Fibrillation Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Rate Control Medications (beta-blockers, calcium channel blockers, digoxin) Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-01-01

PhaseNA

Conditions

Atrial Fibrillation (AF)unresolved

Heart Failure With Mildly Reduced Ejection Fractionunresolved

Heart Failure With Preserved Ejection Fraction (HFPEF)unresolved

Rate Controlunresolved

Rhythm Controlunresolved

Interventions

Catheter Ablation for Atrial FibrillationPROCEDURE

Rate Control Medications (beta-blockers, calcium channel blockers, digoxin)DRUG

Sponsors & collaborators

Nova Scotia Health Authoritylead sponsor

Heart and Stroke Foundation of Canadacollaborator

Mapped research locations

HalifaxNova Scotia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07272902 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.